What AMETEK Investors Need to Know

Industrials sector company AMETEK posted a -0.2% performance today, while the S&P 500 returned 0.8%.

AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices worldwide. The company is based in Berwyn and has 18,500 full time employees. Its market capitalization is $33,227,488,429. AMETEK currently offers its equity investors a dividend that yields 0.6% per year.

15 analysts are following AMETEK and have set target prices ranging from $148 to $170 per share. On average, they have given the company a rating of buy. At today's prices, AME is trading -6.88% away from its average analyst target price of $155.37 per share.

Over the last year, AME's share price has increased by 3.7%, which represents a difference of 16.1% when compared to the S&P 500. The stock's 52 week high is $147.01 per share whereas its 52 week low is $106.17. With an average free cash flow of $1,089,547,666.7 that have been growing at an average rate of 3.1% over the last four years, AMETEK is in a position to continue its strong stock performance trend.

Date Reported Cash Flow from Operations ($ MM) Capital expenditures ($ MM) Free Cash Flow ($ MM) YoY Growth (%)
2021-12-31 1,160 -111 1,050 -13.01
2020-12-31 1,281 -74 1,207 19.24
2019-12-31 1,114 -102 1,012 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.